Market Place
Sourcing Support
United Therapeutics to Feature Data at CHEST 2024 Meeting
24 Sep 2024 //
BUSINESSWIRE
Liquidia Full Approval for Pulmonary Hypertension Drug as Competitor Retains Market Exclusivity
20 Aug 2024 //
BIOSPACE
United Therapeutics Fully Enrolls TETON 2 Study For Inhaled Treprostinil
10 Jul 2024 //
BUSINESSWIRE
Par Pharma recalls blood pressure med for possible contamination
22 Apr 2024 //
FIERCE PHARMA
Enforcement Report - Week of April 3, 2024
03 Apr 2024 //
FDA
Courts clear FDA to approve Liquidia`s PAH drug Yutrepia
02 Apr 2024 //
FIERCE PHARMA
Par Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection
12 Mar 2024 //
PR NEWSWIRE
United Therapeutics starts litigation with FDA over rival Liquidia`s drug application
22 Feb 2024 //
REUTERS
Actavis`s Generic Treprostinil Approval in the U.S.
03 Apr 2023 //
FDA
Liquidia Announces Collaboration to Develop a New Infusion Pump of Treprostinil
05 Dec 2022 //
GLOBENEWSWIRE
United Therapeutics Announces Data From the EXPEDITE Study of Remodulin
31 Oct 2022 //
BUSINESSWIRE
United Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso
11 Oct 2022 //
BUSINESSWIRE
United Therapeutics scraps PhIII in PH with COPD
20 Sep 2022 //
ENPTS
United Therapeutics Corporation Reports Second Quarter 2022 Financial Results
03 Aug 2022 //
BUSINESSWIRE
United Therapeutics Announces FDA Approval of Tyvaso DPI
23 May 2022 //
BUSINESSWIRE
Lung safety review delays FDA decision on United`s Tyvaso DPI
02 Mar 2022 //
FIERCEPHARMA
Ferrer announces distribution agreement United Therapeutics for treprostinil
23 Feb 2022 //
PRESS RELEASE
United Therapeutics Provides Update on Progress of the Tyvaso DPI NDA
18 Oct 2021 //
PRNEWSWIRE
United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The ERS 2021
07 Sep 2021 //
PRNEWSWIRE
United Therapeutics Announces The Lancet Respiratory Medicine Publication
30 Jun 2021 //
PR NEWSWIRE
United Tx Announces FDA Acceptance of Tyvaso DPI NDA For Priority Review
16 Jun 2021 //
PRNEWSWIRE
Liquidia Announces Generic Treprostinil Injection Will Be Available
30 Mar 2021 //
BENZINGA
United axes PAH program Trevyent,once bought for cheap in acquisition of a rival
04 Mar 2021 //
ENDPTS
Alembic Global`s Generic Treprostinil Receives Approval In The US
17 Feb 2021 //
FDA
With pipeline setbacks mounting, United snares priority voucher formulation
29 Dec 2020 //
ENDPTS
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil
09 Dec 2020 //
PRNEWSWIRE
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil
08 Dec 2020 //
PRNEWSWIRE
Lipocine Announces Tentative Approval of TLANDO™
08 Dec 2020 //
PRNEWSWIRE
United Highlights Poster Presentations from the Recent CHEST 2020 Meeting
21 Oct 2020 //
PRNEWSWIRE
United to Present New Tyvaso® Clinical and Treprostinil Real-World Data
15 Oct 2020 //
PRNEWSWIRE
United Therapeutics to Present New Tyvaso® Clinical and Treprostinil
15 Oct 2020 //
PRNEWSWIRE
Alembic Global`s Generic TREPROSTINIL ReceivesTentative Approval In The US
13 Sep 2020 //
FDA
Alembic Pharmaceuticals receives USFDA approval for Treprostinil Injection
07 Sep 2020 //
BUSINESS STANDARD
Alembic Pharma gets tentative USFDA nod to treat pulmonary arterial hypertension
07 Sep 2020 //
ECONOMIC TIMES
Liquidia Announces Notice of Allowance for US Patent Application Methods
28 Aug 2020 //
GLOBENEWSWIRE
United Announces U.S. FDA Filing Acceptance Of sNDA For Tyvaso®
17 Aug 2020 //
PRNEWSWIRE
United Therapeutics Announces Increase Data Presentation at an ATS
17 Jun 2020 //
PR NEWSWIRE
United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement
04 Jun 2020 //
PRNEWSWIRE
Dr Reddys Lab`s Generic Treprostinil Receives Approval in US
28 May 2020 //
FDA
United Therapeutics Announces Additional Results From FREEDOM-EV Study
23 Apr 2020 //
PR NEWSWIR
Liquidia Announces FDA Acceptance of NDA for LIQ861 (treprostinil)
08 Apr 2020 //
GLOBENEWSWIRE
SciPharm Sàrl Generic Treprostinil sodium Receives Approval in Europe
04 Apr 2020 //
EMA
United Therapeutics Announces FDA Approval Of Updated Label For OrenitraM
21 Oct 2019 //
PR NEWSWIRE
Par Sterile`s Generic Treprostinil Receives Approval In US
24 Sep 2019 //
FDA
Correvio Highlights FDA Acceptance of United Therapeutics` Trevyent NDA
11 Sep 2019 //
BIOSPACE
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Sandoz takes United Therapeutics to court for `anticompetitive` behavior
21 Apr 2019 //
BIOPHARMADIVE
United kills its PhIII PAH drug after it fails Tyvaso combo study
09 Apr 2019 //
ENDPTS
Par Sterile`s Generic Treprostinil Receives Tentative Approval in US
21 Dec 2018 //
FDA
Enforcement Report - Week of September 19, 2018
19 Sep 2018 //
FDA
MannKind`s shares rocket up on $105M-plus alliance with United on treprostinil
05 Sep 2018 //
ENDPTS
United Announces Settlement Of Patent Litigation With Watson Relating To Tyvaso
08 Aug 2018 //
PRESS RELEASE
Liquidia files for IPO to challenge United Therapeutics in PAH
03 Jul 2018 //
FIERCE BIOTECH
United Therapeutics, Corsair Pharma sign exclusive licensing pact
04 Jan 2018 //
PHARMABIZ
Corsair & United Thera Enter into Collab to Advance Novel Treprostinil Prodrugs
03 Jan 2018 //
PRESS RELEASE
Sandoz’s Generic Treprostinil Receives Approval In US
04 Dec 2017 //
FDA
Enforcement Report - Week of November 29, 2017
29 Nov 2017 //
FDA
